Improvement of glucose levels by α-lipoic acid has been previously recorded in T2DM cases through improving the diabetes-related deficit in glucose metabolism in addition to activation of insulin signaling pathways [51]. The gene discussed is INS; the disease is type 2 diabetes mellitus.